← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Up Therapeutics, Inc.
Frederick, MD
$2,755,931
Total funding
3
Grants
Funding over time
peak $1.2M · FY2021–24$2M$1.5M$1M$500K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$2,755,931 · 3
By mechanism
R44$2,047,415 · 1
R41$708,516 · 2
Investigators at Up Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of a novel small molecule RPN13 inhibitor and therapeutic for advanced ovarian cancer patients$1,178,998
R44 · FY2024 · CA
Development of a novel small molecule RPN13 inhibitor and therapeutic for advanced ovarian cancer patients$868,417
R44 · FY2023 · CA
Development of small molecule RPN13 inhibitors for Treatment of Glioblastoma$400,000
R41 · FY2022 · CA
Developing a RPN13 inhibitor for the treatment of Quadruple Negative Breast Cancer$253,516
R41 · FY2021 · CA
Developing a RPN13 inhibitor for the treatment of Quadruple Negative Breast Cancer$55,000
R41 · FY2022 · CA